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Abstract
Background:  The detrimental effect of delaying surgical revascularization has been estimated in
randomized trials and observational studies. It has been argued that the Kaplan-Meier method used in
quantifying the hazard of delayed treatment is not appropriate for summarizing the probability of
competing outcomes. Therefore, we sought to improve the estimates of the risk of death associated with
delayed surgical treatment of coronary artery disease.
Methods: Population-based prospective study of 8,325 patients registered to undergo first time isolated
coronary artery bypass grafting (CABG) in any of the four tertiary hospitals that provide cardiac care to
adult residents of British Columbia, Canada. The cumulative incidence of pre-operative death, the
cumulative incidence of surgery, and the probability that a patient, who may die or undergo surgery, dies
if not   operated by certain times over the 52-week period after the decision for CABG were estimated.
The risks were quantified separately in two groups: high-severity at presentation were patients with either
persistent unstable angina or stable angina and extensive coronary artery disease, and low-severity at
presentation were stable symptomatic patients with limited disease.
Results: The median waiting time for surgery was 10 weeks (interquartile range [IQR] 15 weeks) in the
high-severity group and 21 weeks (IQR 30 weeks) in the low-severity group. One percent of patients died
before surgery:   54 in the high-severity and 26 in the low-severity group. For 58 (72.5%) patients, death
was related to CVD (acute coronary syndrome, 33; chronic CVD, 16; other CVD, 4; and sudden deaths,
5). The overall death rate from all causes was 0.61 (95% CI 0.48-0.74) per 1,000 patient-weeks, varying
from 0.62 (95% CI 0.45-0.78) in the high-severity group to 0.59 (95% CI 0.37-0.82) in the low-severity
group. After adjustment for age, sex, and comorbidity, the all-cause death rate in the low-severity group
was similar to the high-severity group (OR = 1.02, 95% CI 0.64-1.62). The conditional probability of death
was greater in the high-severity   group than in the low-severity group both for all-cause mortality (p =
0.002) and cardiovascular deaths (p <0.001).
Conclusion: The probability of death conditional on not having undergone a required CABG increases
with time spent on wait lists.
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Background
Coronary-artery bypass grafting (CABG) is indicated for
revascularizing patients who have limiting angina that
persists despite optimal medical treatment and suitable
coronary anatomy. In a meta-analysis of seven rand-
omized controlled trials of immediate CABG versus med-
ical therapy, surgery has been shown to improve
prognosis in stable symptomatic patients with left main
coronary disease, triple vessel disease, or two vessel dis-
ease involving a significant stenosis of the proximal left
anterior descending coronary artery [1]. It has been
argued that some of the survival benefits could be lost due
to additional deaths resulting from a longer wait for
required revascularization [2]. Methodologically, not
including pre-operative deaths implies that survival time
begins at procedure; and, therefore, treatment effect is
implicitly conditioned on surviving to treatment [3]. Also,
when reporting mortality among patients who may die or
undergo surgery special statistical techniques must be
used to isolate the effect of competing risks of surgery and
death [5]. The Kaplan-Meier method used in reports on
these trials is not appropriate for describing the probabil-
ity of competing outcomes over time [4].
The detrimental effect of delaying CABG surgery has been
estimated as well in observational studies of patients
whose treatment was delayed due to a rationing of access
to care. Population-based studies show that from 0.4 to
1.3 percent of patients scheduled for CABG die preopera-
tively [6-8]. Again, these proportions cannot be studied by
the Kaplan-Meier method as they are affected by the inci-
dence of both surgery and death. Therefore, it is not clear
whether the low observed probabilities of death indicate
a true low risk of death or appropriate timing of surgery.
One measure suggested for summarizing the risk of death
over time in competing-risk setting is the probability of
death conditional on not having experienced the compet-
ing event by a certain time [9,10]. Using this approach, we
sought to improve the estimates of the risk of death asso-
ciated with delayed coronary artery bypass surgery in
patients requiring and suitable for surgical revasculariza-
tion. We, therefore, estimated the time-dependent proba-
bility of death, given that CABG was not performed by
certain times, using data from a prospective database of all
adult patients who were accepted for isolated first time
coronary artery surgery in British Columbia [BC], Canada.
Methods
The University of British Columbia Ethics Board approved
the study protocol.
Data sources
A population-based cardiac registry contains the time of
registration on wait lists for CABG and the time of proce-
dure, or removal from wait lists without surgery, for all
patients who have been accepted for surgical coronary
revascularization in any of the four tertiary hospitals that
provide cardiac care to adult residents of BC since 1991
[11]. The reliability of demographic and clinical data in
the registry has been described elsewhere [12].
The date and cause of death for the registry records were
obtained from BC Linked Health Database Deaths File for
1990 through 2001 [13]. Causes of death were coded
according to the International Classification of Diseases,
9th revision (ICD-9) [14]. Cardiovascular deaths were all
those with ICD-9 codes 410–439 plus sudden deaths due
to unknown causes. Data on coexisting medical condi-
tions were retrieved from the BC Linked Health Database
Hospital Separations File using diagnoses reported in dis-
charge abstracts created during the calendar year before
registration for CABG [15].
Patients
We studied records of patients for whom surgical revascu-
larization was indicated at the time of consultation with a
cardiac surgeon. For this analysis, patients were divided
into high-severity and low-severity at presentation groups
according to angiographic findings, symptom severity and
left ventricular dysfunction (ejection fraction less than
50%) [16].
The high-severity group consisted of patients with either
persistent unstable angina or stable angina and extensive
CAD (left-main stenosis more than 50%, triple-vessel dis-
ease, or double-vessel disease with significant proximal
left anterior descending stenosis and impaired left ven-
tricular function). The low-severity group consisted of sta-
ble symptomatic patients with limited CAD (double-
vessel disease with no lesion in the proximal left anterior
descending artery and normal left ventricular function or
single-vessel disease with significant proximal left anterior
descending stenosis).
There were 8,494 patients identified who required iso-
lated (did not include a valve replacement procedure) first
time coronary artery bypass surgery in these two groups
between January 1991 and December 2000. We excluded
169 records of the patients who were removed on the reg-
istration date (50), had missing operating room reports
(4), or had immediate access to surgery (115). Of those,
161 eventually underwent surgery; seven died; 75 became
unfit for surgery; 100 declined surgery; 16 were transferred
to another surgeon or hospital; and 96 were removed
from wait lists for other reasons. The baseline characteris-
tics of patients are shown in Table 1. The remaining 8,325
patients had either a surgery date or a date and reason for
removal without surgery. The study period ended in
December 2001, allowing only 52 weeks of follow-upBMC Health Services Research 2006, 6:85 http://www.biomedcentral.com/1472-6963/6/85
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after the last patients were added to the list. Therefore, we
restricted the analysis to the first 52 weeks after registra-
tion so that 455 (5.5%) patients remaining on the lists at
12 months were censored. 
Statistical analysis
The primary outcomes were the occurrence of death from
all causes and death related to cardiovascular disease
(CVD) while awaiting coronary artery surgery. The date of
the operating room booking request from surgeon served
as the date of decision for surgery and registration on a
wait list.
In the participating hospitals, surgical wait lists are used to
hold patient names until the surgery can be scheduled.
Patients are also removed from the wait lists without sur-
gery if they die, reconsider the decision to undergo sur-
gery, accept surgery from another surgeon, move out of
the province, or if their conditions deteriorate so that sur-
gery is no longer possible. Details regarding the wait-list
management were published elsewhere [11].
The risk of death as a function of treatment delay is
described by the probability that a patient dies condi-
tional on not having undergone surgery by a certain time
after the registration on a wait list for CABG. The condi-
tional probability function (CPF) of death is interpreted
as the cumulative incidence of deaths by a certain wait-list
week among cardiac surgery patients who had not yet
undergone CABG by that time.
To estimate CPF of death, we first estimated separately the
cumulative incidence of death and the cumulative inci-
dence of surgery over time while treating wait-list remov-
als, other than surgery and death, as censored
observations. The cumulative incidence function of an
event is defined as the integration over time of the product
of the event rate and the probability of remaining on the
list [17]. The following section describes the estimation
procedure.
Suppose the events of death and surgery occur at E dis-
tinct, unevenly spaced, ordered times, ti, for i = 1,2,..., E,
and define t0 = 0. Using Gooley's notation [5], let ei be the
number of deaths at time ti, ri be the number of surgeries
at time ti, ci be the number of censored events at time ti,
and ni = ni-1 - (ei + ri + ci) be the number of patients still
waiting beyond time ti, where n0 is the initial number of
Table 1: Characteristics of 8,325 patients (6,405 in high-severity and 1,920 in low-severity) registered for isolated coronary artery 
bypass surgery in British Columbia, 1991–2000
Characteristic All patients N (%) High-severity N (%) Low-severity N (%)
Age group (y)
<50 679 (8.2) 496 (7.7) 183 (9.5)
50–59 1841 (22.1) 1397 (21.8) 444 (23.1)
60–69 3167 (38.0) 2457 (38.4) 710 (37.0)
70–79 2478 (29.8) 1933 (30.2) 545 (28.4)
≥80 160 (1.9) 122 (1.9) 38 (2.0)
Sex
Women 1473 (17.7) 1102 (17.2) 371 (19.3)
Men 6852 (82.3) 5303 (82.8) 1549 (80.7)
Comorbidity at registration
Major conditions* 1775 (21.3) 1358 (21.2) 417 (21.7)
Other conditions † 2137 (25.7) 1723 (26.9) 414 (21.6)
None 4413 (53.0) 3324 (51.9) 1089 (56.7)
Coronary anatomy
Left-main stenosis 990 (11.9) 990 (15.5) 0 (0.0)
Multi- vessel disease‡ 6672 (80.1) 4986 (77.8) 1686 (87.8)
Limited disease§ 663 (8.0) 429 (6.7) 234 (12.2)
*congestive heart failure, diabetes, chronic obstructive pulmonary disease, rheumatoid arthritis, cancer.
†peripheral vascular disease, cerebrovascular disease, dementia, peptic ulcer disease, hemiplegia, renal disease, or liver disease.
‡3 or 2-vessel disease with PLAD.
§2-vessel disease with no PLAD or 1-vessel disease with PLADBMC Health Services Research 2006, 6:85 http://www.biomedcentral.com/1472-6963/6/85
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patients at risk. As described by Kalbfleisch and Prentice,
a non-parametric estimator for the cumulative incidence
of death at time t, F1(t), is given by the following formula
[18]:
Similarly, a non-parametric estimator for the cumulative
incidence of surgery at time t, F2(t), is
The formula for a Taylor series approximation of the vari-
ance for the cumulative incidence of an event was devel-
oped by Gaynor [19].
The CPF of death, among those who remained untreated,
is defined as the ratio of the cumulative incidence of death
and the complement of cumulative incidence of surgery
[10]. We used the non-parametric estimator for the calcu-
lation of the CPF of death [9]:
Its variance was determined by Pepe in [9]. To estimate
the cumulative incidence of events, CPF of death, and the
corresponding confidence intervals, we used Matlab ver-
sion 7.0.1 [see Additional file1]. A two-sample test was
used to compare the CPF between the study groups [9].
The cumulative incidence of surgery was compared
between the two groups by the Gray's test [20].
We used discrete-time survival regression models to eval-
uate the combined effect of clinical factors that identify
the patient groups in this study on the death rate, while
adjusting for age, sex, and comorbidity [21]. The likeli-
hood ratio test was used to assess whether the models
were consistent with the data [22]. Existing literature sug-
gest that age, sex and comorbidities may be potential con-
founders. Elderly patients are more likely to undergo
revascularization as an urgent procedure. The smaller cor-
onary vessel diameters may account for higher risk of
adverse events in women. Co-existing medical conditions
may delay scheduling surgery. All of these factors were
entered into the regression models. In particular, each
patient was classified as 1) presenting with congestive
heart failure, diabetes, chronic obstructive pulmonary dis-
ease, cancer or rheumatoid arthritis, 2) presenting with
other co-existing chronic conditions as defined in [23], or
3) presenting with no co-existing conditions.
Results
At 52 weeks of follow-up, 7,155 (85.9%) patients under-
went surgery, 80 (1.0%) died while awaiting surgery, 455
(5.5%) patients were remaining on the lists, and 635
(7.6%) dropped out during follow-up for various reasons:
became unfit to surgery (166), declined surgery (181),
transferred to another surgeon or hospital (93), received
other surgery (21), or removed from the list due to other
reasons (174), Table 2. Over 10% of low-severity patients
and less than 5% of high-severity patients were still
untreated at 52 weeks.
The extent of disease was a major factor influencing time
to surgery. The median waiting time for surgery was 10
weeks (interquartile range [IQR] 15 weeks) in the high-
severity group and 21 weeks (IQR 30 weeks) in the low-
severity group. The differences in the cumulative inci-
dence of surgery were significant over time between
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Table 2: Number of patients (%) by 52-week outcome of registration for isolated coronary artery bypass surgery
Outcomes All patients N(%) High-severity N(%) Low-severity N(%)
Underwent surgery 7155 (85.9) 5722 (89.3) 1433 (74.6)
Removed without surgery
Died while waiting 80 (1.0) 54 (0.8) 26 (1.4)
Became unfit for surgery 166 (2.0) 90 (1.4) 76 (4.0)
Patient request 181 (2.2) 131 (2.0) 50 (2.6)
Transferred or moved 93 (1.1) 62 (1.0) 31 (1.6)
Other surgery 21 (0.3) 13 (0.2) 8 (0.4)
Other reason 174 (2.1) 117 (1.8) 57 (3.0)
Still on wait list 455 (5.5) 216 (3.4) 239 (12.4)BMC Health Services Research 2006, 6:85 http://www.biomedcentral.com/1472-6963/6/85
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groups with higher incidence in the high-severity group,
(Gray's two-sample test = 411.8, p < 0.001), Figure 1.
A total of 5,722 surgeries over 87,674 patient-weeks in the
high-severity and 1,433 surgeries over 43,817 patient-
weeks in the low-severity group were done. The average
surgery rate was 6.5 per 100 patients per week of delay in
the high-severity group compared to 3.3 in the low-sever-
ity, the odds ratio (OR) = 0.50 (95% confidence interval
[CI] 0.47–0.53), after adjustment for age, sex, and comor-
bidity. The log-likelihood ratio test, 619.9, df = 5, p <
0.001, does not support the global null hypothesis, sug-
gesting that the model is consistent with data.
One percent of patients died before surgery: 54 in the
high-severity and 26 in the low-severity group. For 58
(72.5%) patients, death was related to CVD (acute coro-
nary syndrome, 33; chronic CVD, 16; other CVD, 4; and
sudden deaths, 5).
The overall death rate from all causes was 0.61 (95% CI
0.48–0.74) per 1,000 patient-weeks, varying from 0.62
(95% CI 0.45–0.78) in the high-severity group to 0.59
(95% CI 0.37–0.82) in the low-severity group. After
adjustment for age, sex, and comorbidity, the all-cause
death rate in the low-severity group was similar to the
high-severity group (OR = 1.02, 95% CI 0.64–1.62). The
log-likelihood ratio, 16.2, df = 5, p < 0.01, test does not
support the global null hypothesis, suggesting that, at
least one regression coefficient differs from zero, and
therefore, the model is consistent with data.
Figure 2 shows the relationship between wait time and the
probability of preoperative death from all causes by sever-
ity group, which was estimated by non-parametric meth-
ods as described in a previous section and also by the
Kapaln-Meier method. Although the all-cause death rate is
similar for the two groups, 0.62 versus 0.59 per 1,000
patient-weeks, longer wait times contributed to a higher
cumulative incidence of death in the low-severity than
high-severity group [11]. The non-parametric cumulative
incidence function provides lower probabilities of death
than the Kaplan-Meier method [24]. At 52 weeks since
registration, the Kaplan-Meier estimates are about 4 times
greater (3.7% versus 0.9%) in the high-severity group, and
2 times greater (3.4% versus 1.5%) in the low-severity
group.
To compare proportions of patients dying by a certain
time among those who had not undergone surgery by that
time, we calculated the conditional probability of death in
each group. The non-parametric estimate of the condi-
tional probability of death was derived from the ratio of
the cumulative incidence of death and the complement of
the cumulative incidence of surgery. The conditional
probability for death from all causes was greater in the
high-severity group than in the low-severity group (Pepe's
two-sample test = 2.8, p  = 0.002), Figure 3. Among
patients who had not undergone CABG by 8, 16, 32 and
52 weeks, the probability to die from all causes was 0.6%
(standard error [SE] 0.1), 1.8% (0.3), 6.8% (0.9) and
14.9% (1.8) in the high-severity group, and 0.6% (0.2),
1.2% (0.3), 3.6% (0.8) and 7.9% (1.5) in the low-severity
group.
The conditional probability for CVD death was greater in
the high-severity group than in the low-severity group
(Pepe's two-sample test = 3.6, p  = 0.0002), Figure 4.
Among patients who had not undergone CABG by 8, 16,
32 and 52 weeks, the probability to die from CVD was
0.6% (0.1), 1.6% (0.3), 5.4% (0.8) and 12.1% (1.7) in the
high-severity group, and 0.3% (0.1), 0.6% (0.2), 2.1%
(0.6) and 4.7% (1.2) in the low-severity group.
Discussion
In this prospective study of 8,325 consecutive patients we
have reported outcomes of delaying coronary artery sur-
gery in two groups of patients for whom isolated CABG
was indicated. The high-severity group included patients
with either persistent unstable angina or stable angina
and extensive CAD at presentation. The low-severity
group included stable symptomatic patients with limited
CAD.
Estimated cumulative incidence of surgery and 95% CIs by  week since registration in high-severity (red) and low-sever- ity (blue) groups; two-sample test = 411.8, p < 0.001 Figure 1
Estimated cumulative incidence of surgery and 95% CIs by 
week since registration in high-severity (red) and low-sever-
ity (blue) groups; two-sample test = 411.8, p < 0.001.
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Estimated probabilities of preoperative death, as cumulative incidence function (blue) and Kaplan-Meier (red) and their stand- ard errors, by week since registration in high-severity and low-severity group Figure 2
Estimated probabilities of preoperative death, as cumulative incidence function (blue) and Kaplan-Meier (red) and their stand-
ard errors, by week since registration in high-severity and low-severity group.
0 4 8 12 16 20 24 28 32 36 40 44 48 52
0
0.01
0.02
0.03
0.04
0.9%
3.7%
WEEK  SINCE  REGISTRATION
C
U
M
U
L
A
T
I
V
E
 
 
P
R
O
B
A
B
I
L
I
T
Y
 
 
O
F
 
 
D
E
A
T
H
HIGH−SEVERITY
0.9%
3.7%
0 4 8 12 16 20 24 28 32 36 40 44 48 52
0
0.01
0.02
0.03
0.04
1.5%
3.4%
WEEK  SINCE  REGISTRATION
C
U
M
U
L
A
T
I
V
E
 
 
P
R
O
B
A
B
I
L
I
T
Y
 
 
O
F
 
 
D
E
A
T
H
LOW−SEVERITYBMC Health Services Research 2006, 6:85 http://www.biomedcentral.com/1472-6963/6/85
Page 7 of 9
(page number not for citation purposes)
In each group, we have estimated the time-dependent
conditional probability that a patient, who may die or
undergo surgery, dies if not operated by certain times.
These probabilities, which summarize competing risks
data on wait-lists, have not been previously reported for
untreated CAD patients for whom CABG was indicated.
As noted by Pepe [9], the conditional probability function
is not a predicted probability and its interpretation does
not require any implicit assumptions. It is simply the pro-
portion of patients who have died among those who
remained untreated. We found that among patients
delayed without treatment for 52 weeks, an estimated
14.9% die in the high-severity group and 7.9% die in the
low-severity group from all causes. Similarly, an estimated
12.1% and 4.7% die from CVD in these two groups.
We report on all-cause and CVD mortality because the
accuracy of death certificate codes is a concern in this anal-
ysis [25], whereas using all-cause mortality could not have
induced any bias in the results. Some evidence that coding
of CVD deaths is accurate comes from a Canadian study
in which the false positive rate was 2.1% and the false neg-
ative rate was 0.4% for myocardial infarction coded as an
underlying cause of death [26]. We also argue that there is
no reason to suspect that there would be differential cod-
ing of death certificates according to urgency of treatment
as the physician completing the death certificate would
not necessarily have been aware of the assigned urgency at
registration for CABG.
In quantifying the risk of preoperative death among
patients needing CABG, the Kaplan-Meier method is com-
monly used to estimate the cumulative probability of
death by certain times after registration for the operation
[27-29]. It has been established, however, the Kaplan-
Meier method is not appropriate for describing the prob-
abilities of competing events since its complement overes-
timates the proportion of events [4]. This method
produces valid probability estimates only in a hypotheti-
cal situation where all competing risks can be removed
without altering the risk of death.
Other investigators have reported the incidence of preop-
erative death per time unit of waiting for CABG [6-
8,27,29-31]. Although accurately describing the instanta-
neous hazard, death rates can not be converted into prob-
abilities of death without an unrealistic and unverifiable
assumption that time to surgery and time to death are
independent [5]. Plomp and colleagues have reported on
the variation in time to deaths among those who died
before surgery [32], but the proportion of CABG candi-
dates dying over follow-up could not be derived from
their figures.
Methodologically, measuring risk of death as a function of
treatment delay in patients awaiting the treatment is sim-
ilar to quantifying the risk of death during follow-up in a
population exposed to competing events [4]. Therefore,
an alternative approach to summarize competing risks
Estimated conditional probability for cardio-vascular death  and 95% confidence intervals, by week since registration in  high-severity (red) and low-severity (blue) groups; two-sam- ple test = 3.6, p < 0.001 Figure 4
Estimated conditional probability for cardio-vascular death 
and 95% confidence intervals, by week since registration in 
high-severity (red) and low-severity (blue) groups; two-sam-
ple test = 3.6, p < 0.001.
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Estimated conditional probability for all-cause death and 95% 
confidence intervals, by week since registration in high-sever-
ity (red) and low-severity groups (blue); two-sample test = 
3.1, p = 0.002.
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data is to estimate the proportion of patients dying by a
certain time among those not receiving treatment by that
time [10]. We used the conditional probability function
suggested as a method for summarizing multiple end-
points in the competing-risks setting by Pepe [33].
There were important limitations to our study. First, we
have not adjusted the CPF of death for available covariates
as the statistical methodology for that is yet to be devel-
oped. Therefore, there is a concern that some other factors
can confound the difference between the two study
groups. However, in our data set both study groups were
distributed similarly over age, sex and comorbidity cate-
gory and differed only by the extent of CAD. The number
of deaths observed does not permit the analysis across
strata. A new update of data in the future will perhaps
allow us to report CPFs by important covariates, such as
sex and age. Also, our analysis lacks data on socioeco-
nomic status. Given social class differences in access to
healthcare and mortality, socioeconomic status is a poten-
tial confounding factor for the observed association
between time to CABG and the risk of death [34]. One
important issue is preferential allocation of hospital
resources [35]. It remains unclear whether directly admit-
ting patients of low priority is done to circumvent long
wait lists, or to substitute for cancelations on the operat-
ing room schedule [11].
The quality of information on dates of registration and
removal is a concern in this analysis as well. Although we
considered the date of the booking request as the date of
decision for surgery, no audit was conducted to verify the
accuracy of coding dates in BCCR records.
In conclusion, the contribution of this paper is the esti-
mated conditional probabilities of death in relation to dif-
ferent delays in the treatment of patients requiring and
suitable for CABG. These summary probabilities derived
from the population-based prospective database suggest
that the risk of death among those remaining untreated
increases with time on wait lists.
Conclusion
Our findings have implications for policies related to
access to elective cardiac surgery. First, in deciding on the
duration of time that the treatment of elective patients can
be safely delayed, surgeons and policy makers should be
aware that the probability of death among untreated
patients does not remain constant over time. Second,
implicit in priority wait lists is the perception of a low risk
of pre-operative death in less severe patients. Our results
demonstrate that policy makers should be aware of an 8%
risk of death in untreated patients with coronary artery
disease judged to be low-severity at presentation, if there
is a protracted delay before revascularization.
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